Magnetic Rotational Exploratory Platform for Coronary Lesions
冠状动脉病变磁旋转探索平台
基本信息
- 批准号:10384033
- 负责人:
- 金额:$ 45.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:3D PrintAcuteAdultAngiographyAnimal ModelAnimalsAtherectomyBloodBlood VesselsBlood flowCadaverCardiacCardiologyCardiovascular DiseasesCathetersCause of DeathCessation of lifeChronicCoronary heart diseaseCoupledDangerousnessData SetDental crownsDevice DesignsDevicesDiamondDistalEconomic BurdenEligibility DeterminationEncapsulatedExcisionFeasibility StudiesFrictionGenerationsGlycerolGoalsGoldHeartHeatingHumanIn VitroInnovation CorpsInstitutionInterventionIrrigationLaboratoriesLegal patentLengthLesionMagnetic Resonance ImagingMagnetismManualsMapsMeasurementMeasuresMechanicsMethodologyModelingMyocardial InfarctionOutcomePathway interactionsPerforationPerformancePhasePositioning AttributePowder dose formProceduresPublishingResearchRiskRoboticsRotationRotational AtherectomiesServicesSpeedState HospitalsStentsSurfaceSystemTestingTimeTo specifyTorqueTraumatic injuryTumor DebulkingUnderserved PopulationUnited StatesUnited States National Institutes of HealthViscosityarmbasebiomaterial compatibilitycalcificationcomparative efficacycoronary artery calcificationcoronary lesioncostdesigneffective therapyefficacy studyheat injuryimprovedin vivomagnetic fieldmeetingsmortalitynegative affectnovelpercutaneous coronary interventionportabilitypre-clinicalpreventprototypesafety assessmentsafety studysafety testingtoolultrasound
项目摘要
Cardiovascular disease (CVD) is the leading cause of mortality in the United States (US), resulting in 850,000
annual deaths, of which nearly 400,000 are associated with coronary heart disease (CHD) and myocardial
infarction (MI). By 2030, global annual deaths will exceed 20 million. More than 90 million US adults currently
live with CVD, which is associated with an annual economic burden of more than $330 billion. Together, MI
and CHD are the most expensive conditions treated in US hospitals, totaling more than $20 billion each year,
with costs expected to double by 2030. Percutaneous coronary intervention (PCI) is an effective strategy to
restore blood flow for obstructive CHD. However, while nearly 950,000 PCI procedures are performed each
year in the US, navigating tortuous vessels is challenging and enabling stent expansion within severely
calcified occlusions often fails, which are observed in ~35% and ~20% of procedures, respectively.
Rotational atherectomy (RA) and orbital atherectomy (OA) are increasingly used to debulk otherwise
untreatable lesions to enable PCI, with recent studies confirming RA and OA improve stent deliverability vs.
standard PCI without negatively affecting outcomes. To debulk severely calcified lesion, RA/OA devices
employ long (>300cm) stiff driveshafts which spin burrs/crowns at speeds up to 180,000 RPM. For both RA
and OA, the inflexible driveshaft often hinders access within tortuous vasculature. The high speeds employed
are necessary to stabilize the burr/crown about a guidewire, without which, the tip would dangerously whip.
However, the need for extreme rotational speeds greatly increases the complexity of RA/OA systems and
presents risks, which include 1) thermal injury due to driveshaft friction, 2) arterial abrasion and perforation, 3)
guidewire shattering, 4) burr/crown entrapment, and 5) embolic debris within the distal vasculature. To reduce
the risk of traumatic injury, RA and OA devices cannot be used for more than five minutes.
UNandUP has developed an interventional cardiology platform consisting of a magnetic access guidewire
and an over-the-wire rotational atherectomy catheter which are controlled using magnetic fields 100X weaker
than an MRI. The magnetic guidewire overcomes vessel tortuosity to improve lesion access, a desirable
feature for PCI in general. For the magnetic atherectomy catheter, applying magnetic forces directly to the burr
eliminates the need for 100X higher driveshaft speeds to stabilize tip rotation. Resultingly, safer and more
efficacious debulking is achieved. Further, driveshaft removal enables concurrent aspiration of embolic debris
near the burr, a feature not possible with current atherectomy devices. The team reflects leading cardiology,
RA/OA, magnetics, and robotics experts. The company maintains partnerships with leading national
laboratories and recently completed an FDA presubmission meeting and I-Corps participation. The proposal’s
aims include building a prototype magnet system, building magnetic guidewire and atherectomy devices, and
evaluating the system’s performance in tortuous cardiac phantoms and published lesion models.
心血管疾病(CVD)是美国死亡率的主要原因(美国),导致85万
年死亡,其中近40万与冠状动脉疾病(CHD)和心肌有关
梗塞(MI)。到2030年,全球年度死亡将超过2000万。目前超过9000万美国成年人
与CVD一起生活,这与年度经济燃烧超过3,300亿美元有关。在一起,mi
冠心病是美国医院治疗的最昂贵的疾病,每年总计超过200亿美元,
预计到2030年的成本将翻倍。经皮冠状动脉干预(PCI)是一种有效的策略
恢复阻塞性冠心病的血流。但是,每次执行了将近950,000个PCI程序
在美国,导航曲折的视频具有挑战性,并使支架在严重的内部扩展
钙化的闭塞通常会失败,分别在约35%和约20%的手术中观察到。
旋转动力控制术(RA)和轨道动脉切除术(OA)越来越多地用于脱身
最近的研究确认了RA和OA改善支架递送VS。
标准PCI而没有负面影响结果。要删除严重计算的病变,RA/OA设备
员工长(> 300厘米)的刚性驱动轴以高达180,000 rpm的速度旋转毛刺/冠。对于两个RA
OA,不灵活的驱动轴通常会阻碍曲折的脉管系统中的访问。使用的高速
对于在导线上稳定Burr/Crown是必要的,否则,尖端会危险地鞭打。
但是,对极端旋转速度的需求大大增加了RA/OA系统的复杂性和
提出风险,其中包括1)由于摩擦摩擦而引起的热损伤,2)动脉磨损和穿孔,3)
Guidewire粉碎,4)毛刺/冠夹,5)远端脉管系统内栓塞碎片。减少
创伤,RA和OA设备的风险不能超过五分钟。
UnAndup开发了一个介入的心脏病学平台,该平台由磁性访问导线组成
和线上的旋转动脉切除术导管,该导管使用磁场弱100倍控制
比MRI。磁性导线克服了血管曲折以改善病变的进入,这是理想的
PCI一般的功能。对于磁性动脉切除术导管,将磁力直接施加到毛刺
消除了对稳定尖端旋转的100倍驱动轴速度的需求。因此,更安全
实现了简单的剪裁。此外,驱动轴除去栓塞碎片的同时抽吸
在毛刺附近,目前的动脉切除术设备不可能。团队反映了领先的心脏病学,
RA/OA,磁和机器人专家。该公司与领先的国家保持伙伴关系
实验室,最近完成了一次FDA预审会议和I-Corps的参与。提案的
目的包括构建原型磁铁系统,构建磁性导线和动脉切除术设备以及
评估系统在曲折的心脏幻象和已发表病变模型中的性能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard Gordon Bach其他文献
Richard Gordon Bach的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard Gordon Bach', 18)}}的其他基金
Magnetic Rotational Exploratory Platform for Coronary Lesions
冠状动脉病变磁旋转探索平台
- 批准号:
10616021 - 财政年份:2022
- 资助金额:
$ 45.64万 - 项目类别:
相似国自然基金
去泛素化酶USP5调控P53通路在伴E2A-PBX1成人ALL的致病机制研究
- 批准号:81900151
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
核基质结合区蛋白SATB1调控CCR7抑制急性T淋巴细胞白血病中枢浸润的作用与机制
- 批准号:81870113
- 批准年份:2018
- 资助金额:55.0 万元
- 项目类别:面上项目
成人及儿童急性淋巴细胞白血病的基因组转录组生物信息学分析方法建立及数据分析
- 批准号:81570122
- 批准年份:2015
- 资助金额:60.0 万元
- 项目类别:面上项目
NR3C1基因突变在成人急性淋巴细胞白血病耐药与复发中的作用与机制研究
- 批准号:81470309
- 批准年份:2014
- 资助金额:75.0 万元
- 项目类别:面上项目
儿童和成人急性T淋巴细胞白血病中miRNA和转录因子共调控网络的差异性研究
- 批准号:31270885
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
相似海外基金
3D Printed Microfluidic Artificial Lung for Veteran Rehabilitation
用于退伍军人康复的 3D 打印微流控人工肺
- 批准号:
10629531 - 财政年份:2023
- 资助金额:
$ 45.64万 - 项目类别:
Assessment of immunogenicity and antigenicity of different human cell types in natural and 3D-printed allografts
评估天然和 3D 打印同种异体移植物中不同人类细胞类型的免疫原性和抗原性
- 批准号:
10353416 - 财政年份:2021
- 资助金额:
$ 45.64万 - 项目类别:
3D Bioprinted Spinal Cord Organoids as a Relay System for Spinal Cord Injury
3D 生物打印脊髓类器官作为脊髓损伤的中继系统
- 批准号:
10677016 - 财政年份:2021
- 资助金额:
$ 45.64万 - 项目类别:
Development of the First-ever Safe and Effective Anterior Chamber Paracentesis Instrument to Treat and Diagnose Ocular Diseases
开发首个安全有效的前房穿刺器械来治疗和诊断眼部疾病
- 批准号:
10325880 - 财政年份:2021
- 资助金额:
$ 45.64万 - 项目类别:
Assessment of immunogenicity and antigenicity of different human cell types in natural and 3D-printed allografts
评估天然和 3D 打印同种异体移植物中不同人类细胞类型的免疫原性和抗原性
- 批准号:
10194232 - 财政年份:2021
- 资助金额:
$ 45.64万 - 项目类别: